Northeast Pharmaceutical: Net profit of 260 million yuan by 2025, a year-on-year decrease of 36.54%

Northeast Pharmaceutical announcement: 2025 operating revenue was 7.075 billion yuan, a year-on-year decrease of 5.70%. Net profit was 260 million yuan, a year-on-year decrease of 36.54%. The profit distribution proposal approved by the company’s board of directors is as follows: using 1.427 billion yuan as the base, a cash dividend of 0.55 yuan (including tax) will be paid to all shareholders for every 10 shares, with bonus shares of 0 shares (including tax), and no capital increase via capitalization of capital reserves.